Solagran Limited (ASX:SLA) Announce Unexpected Efficacy Of Ropren In Treating Severe Alcoholism
The Directors of Solagran Limited (ASX: SLA) are pleased to provide a summary of the results of the Ropren clinical trials conducted at the Skvortsova-Stepanova psychiatric hospital in 2006-07 with serious and critically ill, drug addicted chronic alcoholics.
More: continued here
Filed under: Alcohol / Addiction / Illegal Drugs on February 18th, 2008